These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
166 related items for PubMed ID: 2608692
1. Effects of OKY-046, a selective thromboxane synthetase inhibitor, on blood pressure and thromboxane synthesis in spontaneously hypertensive rats. Gomi T, Ikeda T, Ishimitsu T, Uehara Y. Prostaglandins Leukot Essent Fatty Acids; 1989 Sep; 37(3):139-44. PubMed ID: 2608692 [Abstract] [Full Text] [Related]
2. Intravenous infusion of a selective inhibitor of thromboxane A2 synthetase in man: influence on thromboxane B2 and 6-keto-prostaglandin F1 alpha levels and platelet aggregation. Yui Y, Hattori R, Takatsu Y, Nakajima H, Wakabayashi A, Kawai C, Kayama N, Hiraku S, Inagawa T, Tsubojima M. Circulation; 1984 Oct; 70(4):599-605. PubMed ID: 6434196 [Abstract] [Full Text] [Related]
3. [Effect of OKY-046, a thromboxane synthetase inhibitor, on renal thromboxane synthesis in spontaneously hypertensive rat]. Nakayama D, Ikeda T. Nihon Jinzo Gakkai Shi; 1988 Jan; 30(1):79-84. PubMed ID: 3386014 [No Abstract] [Full Text] [Related]
6. Thromboxane synthesis and blood pressure in spontaneously hypertensive rats. Purkerson ML, Martin KJ, Yates J, Kissane JM, Klahr S. Hypertension; 1986 Dec; 8(12):1113-20. PubMed ID: 3793195 [Abstract] [Full Text] [Related]
7. Effects of a selective thromboxane synthetase inhibitor OKY-046 on experimental diabetic nephropathy. Hora K, Oguchi H, Furukawa T, Hora K, Tokunaga S. Nephron; 1990 Dec; 56(3):297-305. PubMed ID: 2077412 [Abstract] [Full Text] [Related]
8. Thromboxane synthesis inhibition increases renal prostacyclin and prevents renal disease progression in rats with remnant kidney. Zoja C, Perico N, Corna D, Benigni A, Gabanelli M, Morigi M, Bertani T, Remuzzi G. J Am Soc Nephrol; 1990 Nov; 1(5):799-807. PubMed ID: 2133429 [Abstract] [Full Text] [Related]
9. Effect of the infusion of OKY-046, a thromboxane A2 synthase inhibitor, on urinary metabolites of prostacyclin and thromboxane A2 in healthy human subjects. Morio H, Hirai A, Terano T, Tamura Y, Yoshida S. Thromb Haemost; 1993 Mar 01; 69(3):276-81. PubMed ID: 8470052 [Abstract] [Full Text] [Related]
10. Prevention of endotoxin-induced pulmonary hypertension in primates by the use of a selective thromboxane synthetase inhibitor, OKY 1581. Casey LC, Fletcher JR, Zmudka MI, Ramwell PW. J Pharmacol Exp Ther; 1982 Aug 01; 222(2):441-6. PubMed ID: 6896528 [Abstract] [Full Text] [Related]
18. Effect of thromboxane synthetase inhibitors (OKY-046, OKY-1580) on experimentally induced air embolism in anesthetized dogs. Ishihara Y, Uchida Y, Kitamura S. Prostaglandins Leukot Med; 1986 Feb 01; 21(2):197-206. PubMed ID: 3457388 [Abstract] [Full Text] [Related]
19. [Anti-allergic effects of (E)-3-[p-(1H-imidazol-1-ylmethyl)phenyl]-2-propenoic acid (OKY-046), a specific thromboxane (TX) A2 synthetase inhibitor: effect of OKY-046 on II-IV type allergic reactions]. Kikuchi S, Takehana Y, Hamano S, Ichikawa K, Komatsu H, Okegawa T, Ikeda S. Nihon Yakurigaku Zasshi; 1990 Mar 01; 95(3):131-7. PubMed ID: 2141317 [Abstract] [Full Text] [Related]